Premium
Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions
Author(s) -
Nday Christiane M.,
Eleftheriadou Despoina,
Jackson Graham
Publication year - 2018
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/jnc.14256
Subject(s) - disease , dyslipidemia , psychological intervention , cognition , diabetes mellitus , medicine , exacerbation , neuroscience , bioinformatics , psychology , pathology , psychiatry , biology , endocrinology
Alzheimer's disease ( AD ) belongs to one of the most multifactorial, complex and heterogeneous morbidity‐leading disorders. Despite the extensive research in the field, AD pathogenesis is still at some extend obscure. Mechanisms linking AD with certain comorbidities, namely diabetes mellitus, obesity and dyslipidemia, are increasingly gaining importance, mainly because of their potential role in promoting AD development and exacerbation. Their exact cognitive impairment trajectories, however, remain to be fully elucidated. The current review aims to offer a clear and comprehensive description of the state‐of‐the‐art approaches focused on generating in‐depth knowledge regarding the overlapping pathology of AD and its concomitant ailments. Thorough understanding of associated alterations on a number of molecular, metabolic and hormonal pathways, will contribute to the further development of novel and integrated theranostics, as well as targeted interventions that may be beneficial for individuals with age‐related cognitive decline.